A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: The PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [PROMUS element] for the treatment of up to two de novo coronary artery lesions) trial

Journal of the American College of Cardiology

Volumn 57, Issue 16, 2011, Pages 1700-1708

  Stone, Gregg W ^a   Teirstein, Paul S ^b   Meredith, Ian T ^c   Farah, Bruno ^d   Dubois, Christophe L ^e   Feldman, Robert L ^f   Dens, Joseph ^g   Hagiwara, Nobuhisa ^h   Allocco, Dominic J ⁱ   Dawkins, Keith D ⁱ  

^a NewYork Presbyterian Hospital   (United States)

^b SCRIPPS CLINIC   (United States)

^c MONASH MEDICAL CENTRE   (Australia)

^d CLINIQUE PASTEUR   (France)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f Munroe Regional Med Center   (United States)

^g DEPARTMENT OF CARDIOLOGY   (Belgium)

^h TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

ⁱ BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

angioplasty; coronary artery disease; restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; COBALT CHROMIUM; ENOXAPARIN; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; METAL COMPLEX; PLATINUM CHROMIUM; PRASUGREL; TICLOPIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY STENT; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SAFETY; SILENT MYOCARDIAL ISCHEMIA; SINGLE BLIND PROCEDURE; STABLE ANGINA PECTORIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SIROLIMUS; TREATMENT OUTCOME;

EID: 79954416871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.02.016     Document Type: Article

References (19)

1. P.W. Serruys, P. Ruygrok, and J. Neuzner A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 2006 286 294
2. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomised trial JAMA 299 2008 1903 1913 (Pubitemid 351574920)
3. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
4. E. Kedhi, K.S. Joesoef, and E. McFadden Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
5. B.J. O'Brien, J.S. Stinson, S.R. Larsen, M.J. Eppihimer, and W.J. Carroll A platinumchromium steel for cardiovascular stents Biomaterials 31 2010 3755 3761
6. I.B.A. Menown, R. Noad, E.J. Garcia, and I. Meredith The platinum chromium element stent platform: from alloy, to design, to clinical practice Adv Ther 27 2010 129 141
7. A. Farb, M. John, E. Acampado, F.D. Kolodgie, M.F. Prescott, and R. Virmani Oral everolimus inhibits in-stent neointimal growth Circulation 106 2002 2379 2384 (Pubitemid 35244741)
8. G.J. Wilson, B.A. Huibregtse, and E.A. Stejskal Vascular response to a third generation everolimus-eluting stent EuroIntervention 6 2010 512 519
9. I.T. Meredith, R. Whitbourn, and D. Scott PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses EuroIntervention 2011 In press
10. P.W. Serruys, A.T.L. Ong, and J.J. Piek A randomised comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trial EuroIntervention 1 2005 58 65
11. K. Tsuchida, J.J. Piek, and F.J. Neumann One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial) EuroIntervention 1 2005 266 272
12. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
13. P.W. Serruys, S. Silber, and S. Garg Comparison of zotarolimus-eluting and everolimus-eluting coronary stents N Engl J Med 363 2010 136 146
14. T.-Y. Liu, W.-C. Lin, L.-Y. Huang, S.-Y. Chen, and M.-C. Yang Surface characteristics and hemocompatibility of PAN/PVDF blend membranes Polymers for Advanced Technologies 16 2005 413 419 (Pubitemid 40707112)
15. J.C. Lin, S.L. Tiong, and C.Y. Chen Surface characterization and platelet adhesion studies on fluorocarbons prepared by plasma-induced graft polymerization J Biomater Sci Polym Ed 11 2000 701 714
16. C. Simon, J.C. Palmaz, and E.A. Sprague Influence of topography on endothelialization of stents: clues for new designs J Long Term Eff Med Implants 10 2000 143 151 (Pubitemid 30387812)
17. M. Joner, G. Nakazawa, and A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342 (Pubitemid 352001347)
18. D.J. Kereiakes, L.A. Cannon, and R.L. Feldman Clinical and angiographic outcomes following treatment of de novo coronary stenoses with a novel platinum-chromium thin-strut stent: primary results of PERSEUS (a prospective evaluation in a randomized trial of the safety and efficacy of the use of the TAXUS Element paclitaxel-eluting coronary stent system) J Am Coll Cardiol 56 2010 264 271
19. Y. He, A. Maehara, and G.S. Mintz Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion Am J Cardiol 105 2010 1272 1275